Certificate published for every lotSame-day dispatch before 1pm, Monday to FridayFree Royal Mail Tracked 48 over £100
ALTAResearch peptides
Journal17 September 20268 min read7 sections

Are peptides legal in the UK? Research peptides and the law explained

Which laws actually apply to research peptides in the UK, what a supplier can and cannot do, and why research use only is a legal condition rather than a slogan.

In this article7 sections

The short answer to "are peptides legal in the UK" is that buying and possessing the peptides we sell is not an offence, because none is a controlled drug; supplying or promoting them for human use is an offence; and whether a product sold for research counts as a medicine is for the MHRA to decide case by case. The longer answer involves three pieces of legislation, one regulator and a set of conditions that every reputable supplier of research peptides in the UK operates under. This article sets them out. It is general information, not legal advice; the position for any specific compound can change and a solicitor should be consulted before relying on it.

The Misuse of Drugs Act 1971

This is the law that makes a substance "controlled", with criminal penalties for possession and supply. It covers the familiar list: opioids, stimulants, cannabis, benzodiazepines, and, in Class C, anabolic steroids together with growth hormone (somatropin) and chorionic gonadotrophin. Growth-hormone-releasing peptides such as GHRP-6, CJC-1295 and ipamorelin are not on the list, and neither is IGF-1.

The peptides in our catalogue are not on that list. BPC-157, TB-500, GHK-Cu, MOTS-c, epitalon, DSIP, Semax, Selank and retatrutide are not controlled substances in the UK. Possessing them is not an offence. That is the first and most important legal fact, and it is why the trade in research peptides UK-wide exists in the open rather than underground. Growth-hormone secretagogues such as tesamorelin are not controlled drugs either, but they are unlicensed for human use and prohibited in sport; we supply tesamorelin strictly as a laboratory reagent.

The Human Medicines Regulations 2012

This is the legislation that actually governs what a supplier can do. Under the regulations it is an offence to sell, supply or advertise a medicinal product in the UK without a marketing authorisation. A substance becomes a "medicinal product" in one of two ways: by presentation, meaning it is described or marketed as treating or preventing a condition or as affecting physiology, or by function, meaning it may be used by or administered to people to restore, correct or modify a physiological function.

The consequence is that the same vial of peptide can be lawful or unlawful depending on how it is presented and supplied. Sold as a laboratory reagent, with no medicinal claims, for research, it is treated as a chemical rather than a medicine, although the MHRA decides borderline cases one by one. Sold with claims about healing, weight loss, sleep, focus or anything else in a person, or with dosing instructions, or to a customer who has made clear they intend to use it on themselves, it is an unlicensed medicine and supplying it is a criminal offence for the supplier. "Research use only" is therefore not a disclaimer. It is a condition of supply with real obligations on both parties, not a safe harbour: the MHRA looks at how a product is presented and used, not at the label.

The MHRA

The Medicines and Healthcare products Regulatory Agency enforces the Human Medicines Regulations. Its enforcement group has been active against online sellers of unlicensed medicines for years, and since 2023 has focused heavily on the class following the licensed launches of semaglutide and tirzepatide. Sellers who market retatrutide or compounded semaglutide "pens" for weight loss have had stock seized, sites taken down and, in several cases, arrests. Most of those actions involved sellers presenting the product for human use, and that is the line every page on this site is written to stay behind. The MHRA's public statements on retatrutide in 2026 go further than its earlier enforcement record, so read the regulator's current position rather than relying on any supplier's summary, ours included.

Other law that people ask about

The Psychoactive Substances Act 2016 covers substances that affect mental functioning by stimulating or depressing the central nervous system when consumed. Semax and Selank are nootropic peptides and the question of whether they are caught is sometimes raised; a supply offence under the Act depends on whether the supplier knows, or is reckless as to whether, the substance is likely to be consumed for its psychoactive effects, so a research-use label does not settle the question alone. We treat both as reagents, make no claims about their effects in people and refuse orders that indicate consumption.

Anti-doping rules are not law but are binding on athletes. WADA's prohibited list includes BPC-157 (under S0, non-approved substances), TB-500 and thymosin beta-4 (S2), growth hormone secretagogues (S2) and unapproved GLP-1-class compounds such as retatrutide (S0); licensed GLP-1 drugs such as semaglutide are not prohibited but are on WADA's monitoring programme. Anyone subject to testing should treat the entire category as prohibited.

Import and customs: peptides that are not controlled can be imported for research, but shipments from outside the UK are subject to Border Force inspection and, where a product is presented as a medicine, seizure by the MHRA. This is one reason to buy UK-stocked research peptides from a UK supplier rather than ordering from overseas.

What a lawful supplier looks like

A supplier operating within the law will sell peptides as reagents with chemical specifications rather than benefits, publish certificates of analysis, require an 18-plus and research-use declaration, decline orders where the customer indicates human use, refuse to answer questions about dosing or administration, and avoid any imagery or language that presents the product for consumption. A supplier who sells vendor-filled "pens" of prepared solution, publishes protocols, quotes prices per month, or shows before-and-after photographs is presenting a medicine without a licence, whatever the small print says.

What this means for you

If you are buying research peptides UK-wide for laboratory use, the position is straightforward: the compounds we stock are legal to buy and possess, and we sell them lawfully as reagents under our research use policy and terms of sale. What neither we nor any other supplier can lawfully do is help you use them on a person, and correspondence suggesting that intent results in the order being refused. That is not caution for its own sake; it is the condition on which the whole category exists.

Questions people ask

Can you buy peptides in the UK?

Buying and possessing the peptides in our catalogue is not an offence, because none is a controlled drug. None is a licensed medicine in the UK, and supplying one for human use is an offence under the Human Medicines Regulations 2012. Whether a product counts as a medicine is decided case by case by the MHRA, whatever the label says, and its public statements on some compounds, retatrutide in particular, are stricter than that. This is general information, not legal advice.

Are peptides classed as research chemicals in the UK?

Research chemicals is a trade description, not a legal category. In law a peptide is a controlled drug if it is listed under the Misuse of Drugs Act 1971, which the peptides we stock are not. It is a medicinal product under the Human Medicines Regulations 2012 if it is presented as treating or preventing disease, or may be used by or administered to people to modify a physiological function, and the MHRA decides that case by case whatever the label says.

Information, not advice. This article summarises published research; nothing here is guidance on human or veterinary use. Products are sold under our research use policy.

From the lab shelf

The compounds in this article

UK stock, certificates published lot by lot, dispatched the same working day before 1pm. For laboratory research only.

BPC-157 research peptide vialBest sellerNo. 001
Recovery & RepairVial

BPC-157

Body Protection Compound 157

Size
5 mg
HPLC
≥99%
Lot
on request
£17.99£3.60/mg
Semax research peptide vialNo. 015
Brain & FocusVial

Semax

ACTH(4-7)-Pro-Gly-Pro

Size
10 mg
HPLC
99.23%
Lot
R26042903
£21.99£2.20/mg
§ Next

More from the Journal

All articles →